Jump to first page First pregnancy after age 30 (RR 1.48). BMI >29 (RR 1.48). Being a college graduate, independent of OB-GYN history (RR 1.36). (Collaborative.

Slides:

Advertisements

Similar presentations

How will you approach the 35 year old, with a 2 x 2 x 2cm, firm, mobile, well circumscribed non tender mass on the right breast?

Advertisements

Breast Cancer. Introduction Most common female cancer Accounts for 32% of all female cancer 211,300 new cases yearly and rising 40,000 deaths yearly.

Which of the following increases a women’s risk for Breast Cancer? A.Starting her menses at age 14 or older B.Breastfeeding C.Extremely dense breast tissue.

†Source: U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2011 Incidence and Mortality Web-based Report. Atlanta (GA): Department.

Periodic Woman Screening Sheet By Periodic Woman Screening Committee January 2010.

Breast Density A patient guide.

Breast Cancer Risk and Risk Assessment Models

Breast Cancer 101 Barbara Lee Bass, MD, FACS Professor of Surgery

Breast Neoplasm In this section we will be discussing breast neoplasm.

Breast Imaging Made Brief and Simple

Breast cancer screening Recommendations for breast cancer screening چه شواهدی برای خطر وجود دارد؟ برای غربالگری چه باید کرد؟

Heather Brewster Breast Cancer - 5 Year Survivor.

Ductal Carcinoma In-Situ (DCIS)

Proliferative Epithelial lesions of the Breast

Breast Cancer Risk Factors

Breast Pathology Seminar CASE PRESENTATION PART 1 Elba Torres Matundan MD FCAP Victor Carlo Vargas MD FCAP.

ASSESSMENT OF BREAST SYMPTOMS/LUMPS Professor P Grantley Gill Specialists Without Borders Seminar in Surgery Rwanda, September 2010.

BREAST CANCER GROUP 6 :  Nuraini Ikqtiarzune Haryono( )  Tri Wahyu Ningsih ( )  Rani Yuswandaru ( )  Anita Rheza Fitriana Putri( )

Alireza Mohammadzadeh, MD Thoracic Surgeon

Nannozi Ssenkoloto, Program Manager October 8, 2013.

BREAST CANCER OVERVIEW Polly Stephens, M.D.. BREAST ANATOMY.

Epidemiology of Breast Cancer Selected Highlights Jack Cuzick, Ph.D Cancer Research UK London.

Marion C.W. Henry, MD Yale University

NYU Medical Grand Rounds Clinical Vignette Elizabeth Selden, MD PGY-2 November 8, 2011 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.

Factors Associated with Bilateral vs. Unilateral Mastectomy in a Diverse, Population-based Sample of Breast Cancer Patients Sarah T. Hawley, PhD, MPH University.

Menopause: The Journal of The North American Menopause Society

 Determining the Nature of a Breast Abnormality  It is a procedure that may be used to determine whether a lump is a cyst (sac containing fluid) or a.

Breast Carcinoma. Anatomy Epidemiology: 10% 17.1/10 28/10 46/ m world wide 6% develop cancer of the breast in their lifetime. 50,000 to 70,000.

Atoosa Adibi MD. Department of Radiology Isfahan University Of Medical Sciences.

MedPix Medical Image Database COW - Case of the Week Case Contributor: Russell A. Patterson Affiliation: Uniformed Services University.

Cancer Estimated US Cancer Cases Cancer Incidence Rates for Women, USA.

1 Study of Tamoxifen and Raloxifene STAR Larry Wickerham, MD NSABP STAR Project Officer.

First month Second Month First month Second Month Milk line remnant Milk line remnant Accessory axillary breast tissue Accessory axillary breast tissue.

Imaging examinations of breasts

Breast cancer -most common -Second common ( Death ) new case ( 2003 ) diagnosed - Lifetime Risk 2.5 % ( 1-8 )

Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain.

Ovarian Cancer Risk Reduction Taking oral contraceptives for 5 years can reduce your risk of ovarian cancer by up to 50% Hankinson SE, Colditz GA, Hunter.

Breast Cancer Breast Cancer DR/FATMA AL-THOUBAITY ASSOCIATE PROFESSOR SURGICAL CONSULTANT.

IN THE NAME OF GOD BREAST DISEASE E.Naghshineh M.D.

Breast Cancer Screening Steven Stanten MD Rupert Horoupian MD AltaBates Summit Medical Center Oakland, California.

NYU Medical Grand Rounds Clinical Vignette Daniel Diaz, MD Class of 2014 September 4, 2012 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.

March 10, 2014 NURS 330 Human Reproductive Health.

NYU Medical Grand Rounds Clinical Vignette Denise Pate MD, PGY-2 January 27, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.

Gynecological Malignancies. Gynecologic malignancies account for 15% of all cancers in women. Gynecologic malignancies account for 15% of all cancers.

Breast Cancer in the Women’s Health Initiative Trial of Estrogen Plus Progestin For the WHI Investigators Rowan T Chlebowski, MD., Ph.D.

Breast Cancer Prevention Art or Science? Kristi McIntyre M.D. Texas Oncology 2005.

BREAST CANCER: Half a million women later… Amy Miglani M.D September 3, 2004.

Breast Cancer. Breast cancer is a disease in which malignant cells form in the tissues of the breast – “National Breast Cancer Foundation” The American.

2/19/2012 دکتر مریم طباطبائیان. E ARLY DETECTION OF BREAST CANCER 2/19/2012 دکتر مریم طباطبائیان.

HEAPHY 1 & 2 CASE RACE 1 – DIAG Yvonne CLARKE Sat 31 st Aug 2013 Session 3 / CR1-4 13:16 – 13:20 WELLINGTON ABSTRACT Following a woman’s pathway from her.

©2012 Philip Hoekstra, PhD. Ductal Carcinoma: 80% of breast cancers Lobular Carcinoma: 10-16% of breast cancers.

Breast Cancer Screening. Introduction Breast cancer is a fatal disease at advanced stages; however, it can be controlled through prevention and early.

Breast Cancer Screening and Diagnosis

Date of download: 5/28/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Practical Issues in Counseling Healthy Women About.

© Copyright Annals of Internal Medicine, 2016 Ann Int Med. 164 (6): ITC6-1. In the Clinic Breast Cancer Screening and Prevention.

The Elliott Breast Center * Baton Rouge, LA *

Heather Brewster Breast Cancer - 6 Year Survivor.

Screening Tests: A Review. Learning Objectives: 1.Understand the role of screening in the secondary prevention of disease. 2.Recognize the characteristics.

The most proven way to fight breast cancer is early detection!

Breast Screening and Assessment

Breast Cancer Updates Risks, Genetics, DCIS

Fine-needle aspiration of clinically suspicious palpable breast masses with histopathologic correlation Reshma Ariga, M.D., Kenneth Bloom, M.D., Vijaya.

Clinical Pearls and Tools for Optimizing Breast Cancer Risk Assessment

Breast Screening and Risk Assessment

Breast Imaging Ravi Adhikary, MD.

An Audit on Complex hyperplasia reporting at Derriford Hospital

Digital 2D versus Tomosynthesis Screening Mammography among Women Aged 65 and Older in the United States Screening mammography performance metrics are.

Marion C.W. Henry, MD Yale University

Gene promoter methylation analysis in ductal lavage fluid from cancer-free women at high risk for breast cancer and in women undergoing mastectomy for.

Presentation transcript:

Jump to first page First pregnancy after age 30 (RR 1.48). BMI >29 (RR 1.48). Being a college graduate, independent of OB-GYN history (RR 1.36). (Collaborative Group Lancet 1997; 350: ) Alcohol use of over 5 g/day (RR 1.16). Being left handed (RR 2.0). The use of Prempro 0.615/2.5 in the one arm of WHI (RR of invasive breast cancer by year 4 was 1.73; HR = overall risk 1.24; CI = ). Breast Cancer Risk Factors

Jump to first page High Risk for Breast Cancer nFamily history of breast cancer should be 1 st degree relatives. nA history of fibrocystic breast disease particularly with multiple breast biopsies and particularly in a woman with atypical hyperplasia. nPersonal history of breast or ovarian cancer. nAshkenazi Jewish heritage. nA biopsy in the past of lobular carcinoma in situ (LCIS). n5-year calculated risk factor of breast CA diagnosis  1.7%. nAll of the above.

Jump to first page Breast Cancer Risk Into Perspective n Reduction in breast cancer risk: u Breast feeding for over 7 months (RR 0.70). u Moderate exercise risk reduction (RR 0.70). u 1 st full-term pregnancy under age 20 (RR 0.60).

Jump to first page Tools for Breast Cancer Detection n Monthly Self Breast Exam n Periodic physician breast exam n Mammography/ultrasound n MRI n Genetic risk assessment u BRCA1/BRCA2 n Ductal Lavage

Jump to first page Ductal Lavage

Jump to first page Ductal Lavage

Jump to first page Ductal Lavage

Jump to first page Ductal Lavage n Reproducibility of cytologic interpretation n Relationship of cytologic vs histologic atypia n Integration into clinical risk assessment n Role as diagnostic tool n False (-) rate n Further evaluation of abnormal result